Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics
30 March 2021
Download
IPOs of Instil Bio and Connect Biopharma increase net asset value per HBM share by CHF 4.55 (+1.5%)
22 March 2021
Download
Biotech strebt in Rekordzahl an die Börse - aus der «Finanz und Wirtschaft»
16 March 2021
Download
SWIXX SIGNS CEE REGIONAL AGREEMENT WITH JAZZ PHARMACEUTICALS FOR VYXEOS® LIPOSOMAL
15 March 2021
Download
Successful debut on the stock exchange for HBM portfolio company Longboard Pharmaceuticals
15 March 2021
Download
Monte Rosa Therapeutics Announces $95 Million Series C Financing to Accelerate Next-generation Protein Degradation Platform
12 March 2021
Download
Longboard Pharmaceuticals Announces Pricing of Initial Public Offering
12 March 2021
Download
NEURELIS ANNOUNCES CLOSE OF $114 MILLION SERIES D FINANCING ROUND TO ADVANCE NEUROSCIENCE FOCUS
10 March 2021
Download
eGenesis Announces $125 Million Series C Financing
2 March 2021
Download
SWIXX SIGNS CEE REGIONAL AGREEMENT WITH SEAGEN FOR TUKYSA®
1 March 2021
Download
Aktiver Ansatz zahlt sich aus - aus der «Finanz und Wirtschaft» Nr. 16
27 February 2021
Download
NovellusDx Establishes Fore Biotherapeutics and Appoints Dieter Weinand as Chairman of the Board and Usama Malik as Chief Executive Officer and Director of the Board
22 February 2021
Download
Swixx BioPharma SA of Baar, Switzerland announced today that it had signed eighteen deals for new territories and / or products over the past year
5 February 2021
Download
Horizon Therapeutics to acquire HBM portfolio company Viela Bio for USD 3.05 billion in cash
1 February 2021
Download
Arcutis Announces Positive Topline Results from Pivotal DERMIS-1 and -2 Phase 3 Trials of Topical Roflumilast Cream (ARQ-151) in Plaque Psoriasis
1 February 2021
Download
Narrow River Management Announces Formation and Financing of Two New Companies Developing Therapies for Renal Diseases
27 January 2021
Download
Farmalatam Holding Inc. (Farmalisto) achieves investment of US $ 18 million from the IDB Invest, HBM Healthcare Investments Ltd. and Morgan Río Capital Management
15 January 2021
Download
IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncologypdf.
13 January 2021
Download
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
11 January 2021
Download
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China
9 January 2021
Download
Adrenomed Supervisory Board appoints Dr. Wolfgang Baiker as CEO
4 January 2021
Download
Y-MABS Therapeutics and Swixx Complete CEE & RUSSIA Deal on DANYELZA® and OMBURTAMAB
18 December 2020
Download
BioAtla Announces Pricing of Initial Public Offering
15 December 2020
Download
Nuance Pharma Closes Series D Financing
8 December 2020
Download
Seer Announces Pricing of Initial Public Offering
4 December 2020
Download